Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
5,822€
9,62%
Echtzeit-Aktienkurs Emergent Biosolutions Inc.
Bid:
Ask: